Michael A. Pisetsky, Senior Vice President of Operations and Administration at SI-BONE, Inc., executed a significant stock sale on November 4, 2026. The transaction involved the sale of 36,241 shares of common stock, reflecting a strategic move under a 10b5-1 trading plan established on June 13, 2025. This sale is noteworthy as it illustrates the ongoing trading activities of executives within the surgical and medical instruments industry.

SI-BONE, Inc. is a company focused on developing innovative solutions for patients with musculoskeletal disorders. The company operates under the SIC code for Surgical & Medical Instruments & Apparatus. It is headquartered in San Jose, California, and is publicly traded on the NASDAQ under the ticker symbol SIBN. The recent filing, dated November 6, 2026, is part of a series of transactions made by Pisetsky, indicating a pattern of stock management.

According to the filing, Pisetsky sold the shares at a weighted average price of $24.8007, with individual trades executed at prices ranging from $24.00 to $25.25. Following this transaction, Pisetsky retains ownership of 40,167 shares directly, along with 164,444 shares in total, which includes restricted stock units that are yet to be settled. The filing states, "The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated June 13, 2025." This plan allows executives to sell shares in a pre-determined manner to avoid any potential insider trading violations.

This stock sale may affect various stakeholders, including shareholders and potential investors, as it reflects the confidence and financial strategies of the company's leadership. The surgical and medical instruments industry remains highly competitive, and such transactions may influence market perceptions of executive confidence in the company's future.

Looking ahead, the filing does not specify any upcoming actions or additional filings related to this transaction. However, continued monitoring of Pisetsky's trading activities may provide insights into his ongoing confidence in SI-BONE's performance.